These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11358420)

  • 1. How can the risk of long-term consequences of rheumatoid arthritis be reduced?
    Pincus T; Sokka T
    Best Pract Res Clin Rheumatol; 2001 Mar; 15(1):139-70. PubMed ID: 11358420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Disease-modifying effects of glucocorticoids in rheumatoid arthritis].
    Buttgereit F; Burmester G; Bijlsma JW;
    Z Rheumatol; 2007 Oct; 66(6):522-4. PubMed ID: 17571272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inhibition of radiographic progression in rheumatoid arthritis by anti-rheumatic drugs (DMARDs)].
    Suzuki Y; Wakabayashi T; Saito E; Suwa A
    Clin Calcium; 2007 Apr; 17(4):546-52. PubMed ID: 17404484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term impact of early treatment on radiographic progression in rheumatoid arthritis: A meta-analysis.
    Finckh A; Liang MH; van Herckenrode CM; de Pablo P
    Arthritis Rheum; 2006 Dec; 55(6):864-72. PubMed ID: 17139662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment with leflunomide slows radiographic progression of rheumatoid arthritis: results from three randomized controlled trials of leflunomide in patients with active rheumatoid arthritis. Leflunomide Rheumatoid Arthritis Investigators Group.
    Sharp JT; Strand V; Leung H; Hurley F; Loew-Friedrich I
    Arthritis Rheum; 2000 Mar; 43(3):495-505. PubMed ID: 10728741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A proposed revision to the ACR20: the hybrid measure of American College of Rheumatology response.
    American College of Rheumatology Committee to Reevaluate Improvement Criteria
    Arthritis Rheum; 2007 Mar; 57(2):193-202. PubMed ID: 17330293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of the conventional drugs in the treatment of rheumatoid arthritis].
    Fantini F
    Recenti Prog Med; 2003; 94(7-8):330-8. PubMed ID: 12868241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aggressive combination therapy with intra-articular glucocorticoid injections and conventional disease-modifying anti-rheumatic drugs in early rheumatoid arthritis: second-year clinical and radiographic results from the CIMESTRA study.
    Hetland ML; Stengaard-Pedersen K; Junker P; Lottenburger T; Hansen I; Andersen LS; Tarp U; Svendsen A; Pedersen JK; Skjødt H; Lauridsen UB; Ellingsen T; Hansen GV; Lindegaard H; Vestergaard A; Jurik AG; Østergaard M; Hørslev-Petersen K;
    Ann Rheum Dis; 2008 Jun; 67(6):815-22. PubMed ID: 17878209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An index of the three core data set patient questionnaire measures distinguishes efficacy of active treatment from that of placebo as effectively as the American College of Rheumatology 20% response criteria (ACR20) or the Disease Activity Score (DAS) in a rheumatoid arthritis clinical trial.
    Pincus T; Strand V; Koch G; Amara I; Crawford B; Wolfe F; Cohen S; Felson D
    Arthritis Rheum; 2003 Mar; 48(3):625-30. PubMed ID: 12632413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression in early rheumatoid arthritis.
    Combe B
    Best Pract Res Clin Rheumatol; 2009 Feb; 23(1):59-69. PubMed ID: 19233046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence from clinical trials and long-term observational studies that disease-modifying anti-rheumatic drugs slow radiographic progression in rheumatoid arthritis: updating a 1983 review.
    Pincus T; Ferraccioli G; Sokka T; Larsen A; Rau R; Kushner I; Wolfe F
    Rheumatology (Oxford); 2002 Dec; 41(12):1346-56. PubMed ID: 12468813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longer term benefits of treating rheumatoid arthritis: assessment of radiographic damage and physical function in clinical trials.
    Strand V
    Clin Exp Rheumatol; 2004; 22(5 Suppl 35):S57-64. PubMed ID: 15552516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A historical perspective concerning population-based and clinical studies of early arthritis and early rheumatoid arthritis.
    Sokka T; Pincus T
    Clin Exp Rheumatol; 2003; 21(5 Suppl 31):S5-14. PubMed ID: 14969044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient retention and hand-wrist radiograph progression of rheumatoid arthritis during a 3-year prospective study that prohibited disease modifying antirheumatic drugs.
    Paulus HE; Di Primeo D; Sharp JT; Genant HK; Weissman BN; Weisman MH; Sanda M;
    J Rheumatol; 2004 Mar; 31(3):470-81. PubMed ID: 14994390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The underestimated long term medical and economic consequences of rheumatoid arthritis.
    Pincus T
    Drugs; 1995; 50 Suppl 1():1-14. PubMed ID: 8714794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost effectiveness of adding leflunomide to a 5-year strategy of conventional disease-modifying antirheumatic drugs in patients with rheumatoid arthritis.
    Maetzel A; Strand V; Tugwell P; Wells G; Bombardier C
    Arthritis Rheum; 2002 Dec; 47(6):655-61. PubMed ID: 12522841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study.
    Smolen JS; Han C; Bala M; Maini RN; Kalden JR; van der Heijde D; Breedveld FC; Furst DE; Lipsky PE;
    Arthritis Rheum; 2005 Apr; 52(4):1020-30. PubMed ID: 15818697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long-term drug treatment of chronic polyarthritis: current status and perspectives].
    Wollenhaupt J; Langer HE
    Wien Med Wochenschr; 1990 Jun; 140(12):324-33. PubMed ID: 2204217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-controlled, 52-week trial.
    Keystone EC; Kavanaugh AF; Sharp JT; Tannenbaum H; Hua Y; Teoh LS; Fischkoff SA; Chartash EK
    Arthritis Rheum; 2004 May; 50(5):1400-11. PubMed ID: 15146409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are glucocorticoids DMARDs?
    Bijlsma JW; Hoes JN; Van Everdingen AA; Verstappen SM; Jacobs JW
    Ann N Y Acad Sci; 2006 Jun; 1069():268-74. PubMed ID: 16855154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.